Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

被引：0

作者：

Antoine Roquilly

Bruno Francois

Olivier Huet

Yoann Launey

Sigismond Lasocki

Emmanuel Weiss

Melanie Petrier

Yannick Hourmant

Marwan Bouras

Karim Lakhal

Cecilia Le Bel

Delphine Flattres Duchaussoy

Laia Fernández-Barat

Adrian Ceccato

Laurent Flet

Alexandra Jobert

Jeremie Poschmann

Veronique Sebille

Fanny Feuillet

Despoina Koulenti

Antoni Torres

机构：

[1] Nantes Université,ICU Department and Inserm CIC 1435 & UMR 1092

[2] CHU Nantes,Département d’anesthésie réanimation et medecine peri

[3] INSERM,operatoire, CHRU de Brest

[4] Anesthesie Réanimation,Department of Anaesthesia, Critical Care and Perioperative Medicine

[5] CIC 1413,Department of Anesthesiology and Critical Care Medicine

[6] Nantes Université,Department of Anesthesiology and Critical Care

[7] CHU Nantes,2nd Critical Care Department

[8] INSERM,Faculty of Medicine, UQ Centre for Clinical Research

[9] Center for Research in Transplantation and Translational Immunology,undefined

[10] UMR 1064,undefined

[11] University Hospital of Limoges,undefined

[12] Université de Bretagne Occidentale,undefined

[13] Univ Rennes,undefined

[14] CHU Rennes,undefined

[15] University Hospital of Angers,undefined

[16] Université Paris Cité,undefined

[17] INSERM UMR_S1149,undefined

[18] and AP-HP Nord,undefined

[19] Hôpital Beaujon,undefined

[20] CELLEX research laboratories,undefined

[21] CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias,undefined

[22] 06/06/0028),undefined

[23] Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),undefined

[24] Servei de Pneumologia,undefined

[25] Hospital Clinic,undefined

[26] Barcelona,undefined

[27] Universitat de Barcelona,undefined

[28] CIBERES,undefined

[29] Icrea,undefined

[30] IDIBAPS,undefined

[31] Nantes Université,undefined

[32] CHU Nantes,undefined

[33] Pharmacie,undefined

[34] Nantes Université,undefined

[35] CHU Nantes,undefined

[36] DRI,undefined

[37] Département promotion,undefined

[38] cellule vigilances recherche,undefined

[39] Nantes Université,undefined

[40] CHU Nantes,undefined

[41] DRI,undefined

[42] Plateforme de Méthodologie et de Biostatistique,undefined

[43] Nantes Université,undefined

[44] Université de Tours,undefined

[45] CHU Nantes,undefined

[46] CHU Tours,undefined

[47] INSERM,undefined

[48] SPHERE U1246,undefined

[49] Attikon University Hospital,undefined

[50] The University of Queensland,undefined

来源：

Intensive Care Medicine | 2023年 / 49卷

关键词：

Intensive care; Hospital-acquired pneumonia; Interferon-gamma; Immunotherapy; Immunosuppression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：530 / 544

页数：14

共 50 条

[21] Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease
Moss, RB
Mayer-Hamblett, N
Wagener, J
Daines, C
Hale, K
Ahrens, R
Gibson, RL
Anderson, P
Retsch-Bogart, G
Nasr, SZ
Noth, I
Waltz, D
Zeitlin, P
Ramsey, B
Starko, K
PEDIATRIC PULMONOLOGY, 2005, 39 (03) : 209 - 218
[22] VITDAL@ICU: CORRECTION OF VITAMIN D DEFICIENCY IN CRITICALLY ILL PATIENTS - A RANDOMIZED PLACEBO-CONTROLLED TRIAL
Amrein, K.
Schnedl, C.
Christopher, K. B.
Pieber, T. R.
Dobnig, H.
INTENSIVE CARE MEDICINE, 2014, 40 : S126 - S127
[23] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial
H. Bao
Y. Lv
D. Wang
J. Xue
Z. Yan
European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 459 - 466
[24] Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial
Bao, H.
Lv, Y.
Wang, D.
Xue, J.
Yan, Z.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (03) : 459 - 466
[25] Three-month outcomes and cost-effectiveness of interferon gamma-1b in critically ill patients: a secondary analysis of the PREV-HAP trial
Bouras, Marwan
Tessier, Philippe
Poulain, Cecile
Schirr-Bonnans, Solene
Roquilly, Antoine
JOURNAL OF INTENSIVE CARE, 2024, 12 (01):
[26] Efficacy of prucalopride in critically ill patients with paralytic ileus: A pilot randomized double-blind placebo-controlled trial
Jandee, Sawangpong
Wetwittayakhlang, Panu
Boonsri, Pattira
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 362 - 366
[27] Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial
Shadnoush, Mahdi
Zahedi, Hoda
Norouzy, Abdolreza
Sahebkar, Amirhossein
Sadeghi, Omid
Najafi, Atabak
Hosseini, Saeed
Qorbani, Mostafa
Ahmadi, Arezoo
Ardehali, Seyed Hossein
Hosseinzadeh-Attar, Mohammad Javad
PHYTOTHERAPY RESEARCH, 2020, 34 (12) : 3180 - 3188
[28] Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial
Sanaie, Sarvin
Ebrahimi-Mameghani, Mehrangiz
Hamishehkar, Hadi
Mojtahedzadeh, Mojtaba
Mahmoodpoor, Ata
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (09): : 827 - 833
[29] Efficacy of Licorice as Adjunctive Therapy in Critically Ill Patients with COVID-19: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Alikiaie, Babak
Shalamzari, Seyed Mohammad Hosseinian
Soltani, Rasool
Yegdaneh, Afsaneh
Mousavi, Sarah
JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2023, 12 (04) : 141 - 147
[30] A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT HUMAN INTERFERON ALPHA-2A IN PATIENTS WITH AIDS
FRIEDLAND, GH
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1988, 1 (02) : 111 - 118

← 1 2 3 4 5 →